FDA official logo
GSRS logoPFDA official logo

ALPROSTADIL

UNII:F5TD010360
Formula:C20H34O5
Preferred Substance Name:ALPROSTADIL
InChIKey:GMVPRGQOIOIIMI-DWKJAMRDSA-N
GSRS Full Record:

  • 745-65-3
  • (-)-PROSTAGLANDIN E1
  • (11.ALPHA.,13E,15S)-11,15-DIHYDROXY-9-OXOPROST-13-EN-1-OIC ACID
  • (1R,2R,3R)-3-HYDROXY-2-((E)-(3S)-3-HYDROXY-1-OCTENYL)-5-OXOCYCLOPENTANEHEPTANOIC ACID
  • 11.ALPHA.,15(S)-DIHYDROXY-9-OXO-13-TRANS-PROSTENOIC ACID
  • 11.ALPHA.,15.ALPHA.-DIHYDROXY-9-OXO-13-TRANS-PROSTENOIC ACID
  • ALPROSTADIL [EP monograph]
  • ALPROSTADIL [INN]
  • ALPROSTADIL [JAN]
  • ALPROSTADIL [MART.]
  • ALPROSTADIL [ORANGE BOOK]
  • ALPROSTADIL [USAN]
  • ALPROSTADIL [USP IMPURITY]
  • ALPROSTADIL [USP MONOGRAPH]
  • ALPROSTADIL [USP-RS]
  • ALPROSTADIL [VANDF]
  • ALPROSTADIL [WHO-DD]
  • ALPROSTADIL A-CYCLODEXTRIN
  • ALPROSTADIL ALFADEX
  • ALPROSTADIL ALFADEX [JAN]
  • ALPROSTADIL ALFADEX [WHO-DD]
  • ALPROSTAN
  • ALPROX TD
  • CAVEJECT
  • CAVERJECT
  • CYCLOPENTANEHEPTANOIC ACID, 3.ALPHA.-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-
  • CYCLOPENTANEHEPTANOIC ACID, 3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-, (-)-
  • EDEX
  • EGLANDIN
  • LIPLE
  • LIPO PGE1
  • LIPOPROST
  • LIPROSTIN
  • L-PGE1
  • L-PROSTAGLANDIN E1
  • MINPROG
  • NSC 165559
  • ONO 1608
  • PALUX
  • PROST-13-EN-1-OIC ACID, 11,15-DIHYDROXY-9-OXO-, (11.ALPHA.,13E,15S)-
  • PROST-13-EN-1-OIC ACID, 11,15-DIHYDROXY-9-OXO-, (11A,13E,15S)-
  • PROSTAGLANDIN E1
  • PROSTAGLANDIN E1 [MI]
  • PROSTANDIN
  • PROSTANDIN 500
  • PROSTIN VR PEDIATRIC
  • PROSTIVAS
  • SEPA-ALPROSTADIL
  • SEPA-PGE1
  • SEPA-PROSTAGLANDIN E1
  • TOPIGLAN
  • U 10136
  • U-10136
  • VASAPROSTAN



UNII - F5TD010360 | UNII Search Service